Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. scores highest on Earnings (55) and lowest on Price (2). Its PosiPenta is 26.91 out of 100, weaker than most similar companies.
On the Penta Grid this week, Inovio Pharmaceuticals, Inc. is Grid #798 of 837 in the Healthcare sector in United States, and Grid #3,758 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Inovio Pharmaceuticals, Inc. | 26.91 | 2 | 55 | 40 | 9 | 29 |
| Tenaya Therapeutics, Inc. | 33.72 | 37 | 50 | 18 | 41 | 23 |
| Aardvark Therapeutics, Inc. | 40.38 | 38 | 31 | 24 | 58 | 51 |
| Rallybio Corporation | 71.73 | 85 | 49 | 94 | 89 | 41 |
| Tonix Pharmaceuticals Holding Corp. | 34.67 | 46 | 28 | 16 | 56 | 26 |
| NeOnc Technologies Holdings, Inc. | 43.24 | 0 | 43 | 22 | 94 | 57 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.10 |
| P/B ratio | 23.42 |
EEarnings
| Trailing EPS | ₹-85.24 |
| Forward EPS | ₹-41.67 |
NNitro
| Price | 93.78 |
| 52-week high | 257.62 |
| 52-week low | 53.04 |
| Fall from 52-week high | 63.6% |
TTorque
| Return on equity (ROE) | -409.87% |
| Debt-to-equity | 1.83 |
AAnchor
| Beta (price swings) | 1.61 |
| Market cap | ₹969 Cr |
| Insider holding | 0.33% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Inovio Pharmaceuticals, Inc.'s PosiPenta score?
Inovio Pharmaceuticals, Inc.'s PosiPenta is 26.91 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Inovio Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Inovio Pharmaceuticals, Inc. is Grid #798 of 837 in the Healthcare sector in United States, and Grid #3,758 of 4,000 in United States.
Which PosiPenta pillar is strongest for Inovio Pharmaceuticals, Inc.?
Earnings (growth), with a score of 55 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Inovio Pharmaceuticals, Inc.?
Price (valuation), with a score of 2 out of 100: much weaker than most similar companies.
Has Inovio Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 4.04 points, from 22.87 to 26.91.
PositoAI is for research and education only and is not investment advice.